Parallel stock

Parallel Stock

Consumer Products

Looking to sell Parallel stock or options?

Contact us
Founded: 2014Funding to Date: $228M
Visit website

Parallel, a producer of medical products derived from cannabis, is devoted to enhancing health and well-being. It boasts an extensive array of exclusive brands that are provided in different formats including flower, pre-rolls, vaporizer pens, tinctures, oral sprays, topical creams, time-released transdermal patches, soft gels and cannabis-infused products. These offerings are designed to aid consumers in enhancing their life quality through the advantages of cannabinoids.

Investors Include:

Poseidon Asset Management, Patrón Tequila, StartX (US), New World Health, G5 Capital (Greenwich), Wychwood Asset Management, Valkyrie Capital, LFG Ventures (VC).

Collective Representative

Looking to sell Parallel Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you

Loading